Published in Clin Immunol Immunopathol on July 01, 1990
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol (2009) 4.53
Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol (2000) 4.07
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood (1993) 2.59
Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood (2000) 2.46
17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest (1992) 2.43
Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med (1997) 2.37
Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. Immunology (1996) 2.34
The immune system in extreme longevity. Exp Gerontol (2007) 2.15
Prostacyclin synthesis induced in vascular cells by interleukin-1. Science (1985) 2.13
Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol (2000) 2.10
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10
Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) (2000) 2.09
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol (1995) 2.06
A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis. Exp Dermatol (1992) 2.04
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol (1997) 2.02
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol (2000) 2.01
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol (2001) 1.95
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest (1995) 1.91
Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest (1994) 1.90
Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest (1995) 1.68
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab (1996) 1.68
Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet (1992) 1.68
Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol (1999) 1.65
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol (1985) 1.57
Physical activity is negatively associated with the metabolic syndrome in the elderly. QJM (2008) 1.57
Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res (1993) 1.55
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol (2001) 1.55
Pili torti and onychodysplasia. Report of a previously undescribed hidrotic ectodermal dysplasia. Dermatologica (1991) 1.54
The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol (1999) 1.53
Macrophage control of inflammation: negative pathways of regulation of inflammatory cytokines. Novartis Found Symp (2001) 1.51
Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J Leukoc Biol (1999) 1.50
The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol Appl Pharmacol (1979) 1.49
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol (2001) 1.47
Osteocalcin levels in diabetic subjects. Calcif Tissue Int (1989) 1.45
Alternative approaches to the prognostic stratification of mild to moderate primary vesicoureteral reflux in children. J Urol (1996) 1.44
Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist. Blood (1994) 1.43
Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors. Int J Cancer (1980) 1.43
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Longins: a new evolutionary conserved VAMP family sharing a novel SNARE domain. Trends Biochem Sci (2001) 1.41
Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology (1987) 1.37
Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood (1998) 1.34
Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19. Eur J Immunol (2001) 1.33
Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol (2001) 1.31
Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. J Virol Methods (1991) 1.23
Inhibition of human natural killer activity by cyclosporin A. Transplantation (1981) 1.22
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J Immunol (2000) 1.21
Human large granular lymphocytes are potent producers of interleukin-1. Nature (1984) 1.18
Osteocytes and WNT: the mechanical control of bone formation. J Dent Res (2010) 1.17
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. Leukemia (2012) 1.16
Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell. J Cell Biol (1998) 1.16
Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol (2000) 1.14
Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology (1993) 1.13
The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. Ann Intern Med (1990) 1.13
In vitro migration of human large granular lymphocytes. J Immunol (1985) 1.12
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. Eur J Haematol (1989) 1.11
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int (1986) 1.10
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood (1983) 1.10
Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol (2001) 1.10
Persistence of asexuality through mixed reproduction in Eucypris virens (Crustacea, Ostracoda). Heredity (Edinb) (2000) 1.10
Chemokines: a superfamily of chemotactic cytokines. Int J Clin Lab Res (1996) 1.09
Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immun (1986) 1.09
Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle. EMBO J (2000) 1.09
Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res (1997) 1.09
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood (1989) 1.08
A 2.6 Mb deletion of 6q24.3-25.1 in a patient with growth failure, cardiac septal defect, thin upperlip and asymmetric dysmorphic ears. Eur J Med Genet (2007) 1.08
Chromosome size and number polymorphisms in Leishmania infantum suggest amplification/deletion and possible genetic exchange. Mol Biochem Parasitol (1989) 1.08
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer (1998) 1.08
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres. Haemophilia (2007) 1.08
Chemokines and dendritic cell traffic. J Clin Immunol (2000) 1.08
T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells. J Exp Med (1985) 1.07
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int (2008) 1.06
Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int J Cancer (1989) 1.05
Inhibition of natural killer activity by human bronchoalveolar macrophages. J Immunol (1982) 1.05
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J Immunol (1997) 1.05
Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Leukemia (2010) 1.05
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol (1997) 1.04
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med (1993) 1.04
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol (2000) 1.03
The atypical serine proteases of the complement system. Adv Immunol (1998) 1.03
Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med (1987) 1.03